Gene Therapy Manufacturing Hitch Solved, Bluebird Aims For European Debut In 2020

First Treatment Expected In Germany

 
• By Andrew McConaghie
  
EMA_Amsterdam
The EMA is now satisfied with bluebird's ‘refined manufacturing specifications’ • Source: EMA
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies